[HTML][HTML] Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis
Background Evidence suggests lungs as the organ most affected by coronavirus disease
2019 (COVID-19). The literature on previous coronavirus infections reports that patients may …
2019 (COVID-19). The literature on previous coronavirus infections reports that patients may …
Pulmonary fibrosis in COVID‐19 survivors: Predictive factors and risk reduction strategies
Although pulmonary fibrosis can occur in the absence of a clear‐cut inciting agent, and
without a clinically clear initial acute inflammatory phase, it is more commonly associated …
without a clinically clear initial acute inflammatory phase, it is more commonly associated …
Lung fibrosis after COVID-19: treatment prospects
At the end of 2019, a highly contagious infection began its ominous conquest of the world. It
was soon discovered that the disease was caused by a novel coronavirus designated as …
was soon discovered that the disease was caused by a novel coronavirus designated as …
[HTML][HTML] Pharmacological properties and underlying mechanisms of curcumin and prospects in medicinal potential
YS Fu, TH Chen, L Weng, L Huang, D Lai… - Biomedicine & …, 2021 - Elsevier
Curcumin, isolated from Curcuma longa L., is a fat-soluble natural compound that can be
obtained from ginger plant tuber roots, which accumulative evidences have demonstrated …
obtained from ginger plant tuber roots, which accumulative evidences have demonstrated …
Physical medicine and rehabilitation and pulmonary rehabilitation for COVID-19
TJ Wang, B Chau, M Lui, GT Lam, N Lin… - American journal of …, 2020 - journals.lww.com
This analysis extrapolates information from previous studies and experiences to bring
physical medicine and rehabilitation perspective and intervention to the multidisciplinary …
physical medicine and rehabilitation perspective and intervention to the multidisciplinary …
Animal and translational models of SARS-CoV-2 infection and COVID-19
COVID-19 is causing a major once-in-a-century global pandemic. The scientific and clinical
community is in a race to define and develop effective preventions and treatments. The …
community is in a race to define and develop effective preventions and treatments. The …
SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis
Background Severe acute respiratory syndrome (SARS)-CoV-2-induced coronavirus
disease-2019 (COVID-19) is a pandemic disease that affects> 2.8 million people worldwide …
disease-2019 (COVID-19) is a pandemic disease that affects> 2.8 million people worldwide …
SARS-CoV-2: characteristics and current advances in research
Y Yang, Z **ao, K Ye, X He, B Sun, Z Qin, J Yu, J Yao… - Virology journal, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection has
spread rapidly across the world and become an international public health emergency. Both …
spread rapidly across the world and become an international public health emergency. Both …
Neutrophil extracellular traps (NETs) and damage‐associated molecular patterns (DAMPs): two potential targets for COVID‐19 treatment
S Cicco, G Cicco, V Racanelli… - Mediators of …, 2020 - Wiley Online Library
COVID‐19 is a pandemic disease caused by the new coronavirus SARS‐CoV‐2 that mostly
affects the respiratory system. The consequent inflammation is not able to clear viruses. The …
affects the respiratory system. The consequent inflammation is not able to clear viruses. The …
Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis
Objective Although complications and clinical symptoms of COVID-19 have been elucidated,
the prevalence of long-term sequelae of COVID-19 is less clear in previously hospitalized …
the prevalence of long-term sequelae of COVID-19 is less clear in previously hospitalized …